Difference between revisions of "Raymond Borrow"
(New page: {{Template:Pharma_Portal_badge}} Dr '''Ray Borrow'''is the Head of Vaccine Evaluation Department at the Manchester Medical Microbiology Partnership. He is a member of the [[Joint Committe...) |
|||
| Line 1: | Line 1: | ||
{{Template:Pharma_Portal_badge}} | {{Template:Pharma_Portal_badge}} | ||
| − | Dr '''Ray Borrow'''is the Head of Vaccine Evaluation Department at the Manchester Medical Microbiology Partnership. He is a member of the [[Joint Committee on Vaccination and Immunisation]] ([[JCVI]]). Borrow has occasionally served as a member on expert panels for [[Baxter Bioscience]]; [[GlaxoSmithKline]] ([[GSK]]); [[Novartis]]; [[Sanofi Pasteur]]; and [[Wyeth]] and has served on the medical-scientific advisory panel for the [[Meningitis Trust]] and [[Meningitis Research Foundation]].[[GSK]], [[Sanofi Pasteur]], [[Novartis]] and [[Wyeth]] have paid for his travel to attend scientific organised meetings organised by them. He has conducted biochemical tests (immunossays) for: [[Merck]] for its [[HPV]] vaccine; [[Wyeth]], [[Emergent BioSolutions]], [[Novartis]], [[Baxter Biosciences]], [[Sanofi Pasteur MSD]], [[GSK]] and [[Merck]] for Neisseria meningitidis. <ref>DoH:JCVI. [http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_109120.pdf DECLARATIONS OF INTEREST FOR JCVI MEMBERS 14 OCTOBER 2009] Accessed 15 February 2010.</ref> | + | Dr '''Ray Borrow''' is the Head of Vaccine Evaluation Department at the Manchester Medical Microbiology Partnership. He is a member of the [[Joint Committee on Vaccination and Immunisation]] ([[JCVI]]). Borrow has occasionally served as a member on expert panels for [[Baxter Bioscience]]; [[GlaxoSmithKline]] ([[GSK]]); [[Novartis]]; [[Sanofi Pasteur]]; and [[Wyeth]] and has served on the medical-scientific advisory panel for the [[Meningitis Trust]] and [[Meningitis Research Foundation]].[[GSK]], [[Sanofi Pasteur]], [[Novartis]] and [[Wyeth]] have paid for his travel to attend scientific organised meetings organised by them. He has conducted biochemical tests (immunossays) for: [[Merck]] for its [[HPV]] vaccine; [[Wyeth]], [[Emergent BioSolutions]], [[Novartis]], [[Baxter Biosciences]], [[Sanofi Pasteur MSD]], [[GSK]] and [[Merck]] for Neisseria meningitidis. <ref>DoH:JCVI. [http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_109120.pdf DECLARATIONS OF INTEREST FOR JCVI MEMBERS 14 OCTOBER 2009] Accessed 15 February 2010.</ref> |
==Notes== | ==Notes== | ||
Latest revision as of 22:37, 16 February 2010
|
This article is part of the Pharma_Portal project of Spinwatch. |
Dr Ray Borrow is the Head of Vaccine Evaluation Department at the Manchester Medical Microbiology Partnership. He is a member of the Joint Committee on Vaccination and Immunisation (JCVI). Borrow has occasionally served as a member on expert panels for Baxter Bioscience; GlaxoSmithKline (GSK); Novartis; Sanofi Pasteur; and Wyeth and has served on the medical-scientific advisory panel for the Meningitis Trust and Meningitis Research Foundation.GSK, Sanofi Pasteur, Novartis and Wyeth have paid for his travel to attend scientific organised meetings organised by them. He has conducted biochemical tests (immunossays) for: Merck for its HPV vaccine; Wyeth, Emergent BioSolutions, Novartis, Baxter Biosciences, Sanofi Pasteur MSD, GSK and Merck for Neisseria meningitidis. [1]
Notes
- ↑ DoH:JCVI. DECLARATIONS OF INTEREST FOR JCVI MEMBERS 14 OCTOBER 2009 Accessed 15 February 2010.
